dermatology-2019-posters

3 / 3

Note:
Page 36
April 11-12, 2019 | Barcelona, Spain
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
YEARS
Dermatology 2019 Research in Clinical Dermatology | Volume 2
3rd WORLD DERMATOLOGY
AND COSMETOLOGY CONGRESS
ASSOCIATION OF FUNCTIONAL POLYMORPHISM IN PROTEIN TYROSINE PHOSPHATASE
NON-RECEPTOR 22 (PTPN22) GENEWITHVITILIGO SUSCEPTIBILITY
Ghaleb Bin Huraib
Medical Services Department for Armed Forces, Saudi Arabia
V itiligo is an acquired, autoimmune skin disorder characterized by melanocyte loss resulting into progres-
sive depigmentation of skin and hair. Several genes have been implicated in the pathogenesis of vitiligo.
The protein tyrosine phosphatase non-receptor 22 (PTPN22) gene, which encodes the lymphoid tyrosine phos-
phatase (LYP) protein, is a non-HLA gene associated with autoimmune diseases. The functional PTPN22 C1858T
(R620W) polymorphism is widely associated with an increased risk for vitiligo in Europeans however contro-
versy exits in other populations. The aim of this study was to determine if the PTPN22 C1857T polymorphism
confers susceptibility to vitiligo in Saudi population. Genomic DNA was extracted and amplified using tetra
primer ARMS-PCR method for detection of PTPN22 C1857T polymorphism. We genotyped 125 Saudi vitiligo
patients and 200 healthy controls. The frequencies of alleles and genotypes in patients and healthy controls
were compared. The frequency of T- allele and CT genotype of PTPN22 C1858T polymorphismwas significantly
higher while the frequency of C-allele and CC genotype was lower in patients as compared to controls (P 
0.0001). The homozygous genotype TT was absent in both the patients and controls. These results indicated
that individuals containing allele T are susceptible to vitiligo. We conclude that PTPN22 C1858T polymorphism
is strongly associated with susceptibility to vitiligo with a relative risk of >97 and can be developed as biomark-
er for evaluating vitiligo risk. However, further studies on PTPN22 C1857T polymorphism in larger samples from
different geographical areas and ethnicity are warranted.
Ghaleb Bin Huraib, Res Clin Dermatol 2019, Volume 2
Ghaleb Bin Huraib has completed his PhD in dermatological and venereal diseases from Fribourge University, Germany. Earlier he
did MBBS from faculty of medicine / King Saud University, Riyadh. He is the deputy director of Medical Services Department (MSD)
for armed forces, Saudi Arabia. He has published several papers on genetic basis of dermatological diseases.
BIOGRAPHY